La detección de la inactividad en las poblaciones de edad avanzada: el potencial discriminatorio de la escala de

Fatma Ayvat1, Mert Doğan2, Ender Ayvat3

  • 1Faculty of Physical Therapy and Rehabilitation, Hacettepe University, Samanpazarı/Altındag, 06100, Ankara, Turkey. fatma.avcu@hacettepe.edu.tr.

BMC public health
|August 27, 2025
PubMed
Resumen

La Escala de Actividad Física para Personas Mayores (PASE) tiene una puntuación de corte de 67 para identificar la inactividad física en adultos mayores. Esta herramienta muestra una precisión moderada y debe complementar otras evaluaciones para una evaluación integral.

Videos de Conceptos Relacionados

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...